About CUTISS
CUTISS is a company based in Zurich (Switzerland) founded in 2017 by Daniela Marino and Fabienne Hartmann-Fritsch. It operates as a Product-as-a-Service. CUTISS has raised $94.37 million across 13 funding rounds from investors including Zurcher Kantonalbank, European Union and GISEV. CUTISS offers products and services including denovoSkin™. CUTISS operates in a competitive market with competitors including Humacyte, Tissue Regenix, Acera Surgical, Solsys Medical and Heartseed, among others.
- Headquarter Zurich, Switzerland
- Founders Daniela Marino, Fabienne Hartmann-Fritsch
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cutiss Ag
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$94.37 M (USD)
in 13 rounds
-
Latest Funding Round
$39.01 M (USD), Series C
Sep 10, 2025
-
Investors
Zurcher Kantonalbank
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CUTISS
CUTISS offers a comprehensive portfolio of products and services, including denovoSkin™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Personalized skin tissue therapy is developed for surgeries.
Unlock access to complete
Funding Insights of CUTISS
CUTISS has successfully raised a total of $94.37M across 13 strategic funding rounds. The most recent funding activity was a Series C round of $39.01 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 13
- Last Round Series C — $39.0M
-
First Round
First Round
(01 Sep 2017)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2025 | Amount | Series C - CUTISS | Valuation |
investors |
|
| May, 2024 | Amount | Series C - CUTISS | Valuation | Cherry Bay Capital Group | |
| Jan, 2022 | Amount | Grant - CUTISS | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CUTISS
CUTISS has secured backing from 10 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include Zurcher Kantonalbank, European Union and GISEV. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Cherry Bay Capital Group is engaged in wealth advisory and investment services.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CUTISS
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CUTISS
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cutiss Comparisons
Competitors of CUTISS
CUTISS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Humacyte, Tissue Regenix, Acera Surgical, Solsys Medical and Heartseed, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Human tissue-based products are developed for vascular disease applications.
|
|
| domain | founded_year | HQ Location |
Developer of regenerative medical devices by using cell technology
|
|
| domain | founded_year | HQ Location |
Synthetic electrospun scaffolds are provided for regenerative medical uses.
|
|
| domain | founded_year | HQ Location |
Human skin allografts and dressings for wound care are supplied.
|
|
| domain | founded_year | HQ Location |
Developer of myocardial regenerative medicine for treating heart diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cutiss
Frequently Asked Questions about CUTISS
When was CUTISS founded?
CUTISS was founded in 2017.
Where is CUTISS located?
CUTISS is headquartered in Zurich, Switzerland.
Who is the current CEO of CUTISS?
Daniela Marino is the current CEO of CUTISS. They have also founded this company.
Is CUTISS a funded company?
CUTISS is a funded company, having raised a total of $94.37M across 13 funding rounds to date. The company's 1st funding round was a Grant of $339.62K, raised on Sep 01, 2017.
What does CUTISS do?
Skin tissue therapeutics are pioneered by CUTISS, a TechBio company focused on bioengineering. Personalized therapy, denovoSkin, is manufactured for skin surgeries including burns and reconstructive applications. Solutions are produced at a GMP facility in Zurich, Switzerland, using automated, scalable platforms. The technology supports regenerative medicine, space health research, and industrial bioengineered tissues. Expansion into other tissues like gums and cornea is targeted for accessible treatments.
Who are the top competitors of CUTISS?
CUTISS's top competitors include Humacyte, Acera Surgical and Heartseed.
What products or services does CUTISS offer?
CUTISS offers denovoSkin™.
Who are CUTISS's investors?
CUTISS has 10 investors. Key investors include Zurcher Kantonalbank, European Union, GISEV, Rode Kruis Ziekenhuis, and Cherry Bay Capital Group.